These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 17644065)

  • 1. Endostar, a novel recombinant human endostatin, exerts antiangiogenic effect via blocking VEGF-induced tyrosine phosphorylation of KDR/Flk-1 of endothelial cells.
    Ling Y; Yang Y; Lu N; You QD; Wang S; Gao Y; Chen Y; Guo QL
    Biochem Biophys Res Commun; 2007 Sep; 361(1):79-84. PubMed ID: 17644065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gambogic acid inhibits angiogenesis through suppressing vascular endothelial growth factor-induced tyrosine phosphorylation of KDR/Flk-1.
    Lu N; Yang Y; You QD; Ling Y; Gao Y; Gu HY; Zhao L; Wang XT; Guo QL
    Cancer Lett; 2007 Dec; 258(1):80-9. PubMed ID: 17920764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endostar, a modified recombinant human endostatin, exhibits synergistic effects with dexamethasone on angiogenesis and hepatoma growth.
    Li XQ; Shang BY; Wang DC; Zhang SH; Wu SY; Zhen YS
    Cancer Lett; 2011 Feb; 301(2):212-20. PubMed ID: 21216091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
    Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
    Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
    Huang SW; Lien JC; Kuo SC; Huang TF
    Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oroxylin A inhibits angiogenesis through blocking vascular endothelial growth factor-induced KDR/Flk-1 phosphorylation.
    Gao Y; Lu N; Ling Y; Chen Y; Wang L; Zhao Q; Qi Q; Liu W; Zhang H; You Q; Guo Q
    J Cancer Res Clin Oncol; 2010 May; 136(5):667-75. PubMed ID: 19888602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endostatin blocks vascular endothelial growth factor-mediated signaling via direct interaction with KDR/Flk-1.
    Kim YM; Hwang S; Kim YM; Pyun BJ; Kim TY; Lee ST; Gho YS; Kwon YG
    J Biol Chem; 2002 Aug; 277(31):27872-9. PubMed ID: 12029087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human recombinant endostatin Endostar attenuates hepatic sinusoidal endothelial cell capillarization in CCl4‑induced fibrosis in mice.
    You Q; Kong LJ; Li FD; Wang HY; Liu DG; Pei FH; Song JT; Xu J; Chen J
    Mol Med Rep; 2015 Oct; 12(4):5594-600. PubMed ID: 26239504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of alpha-tocopherol ether-linked acetic acid in VEGF-induced angiogenesis and the possible mechanisms in human umbilical vein endothelial cells.
    Chuang CH; Liu CH; Lu TJ; Hu ML
    Toxicol Appl Pharmacol; 2014 Dec; 281(3):310-6. PubMed ID: 25447407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ZLM-7 exhibits anti-angiogenic effects via impaired endothelial cell function and blockade of VEGF/VEGFR-2 signaling.
    Su M; Huang J; Li J; Qin X; Tang X; Jin F; Chen S; Jiang C; Zou Z; Peng K; Nuruzzaman M; Zhang J; Luo J; Liu S; Luo Z
    Oncotarget; 2016 Apr; 7(14):19018-30. PubMed ID: 26967559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emodin inhibits vascular endothelial growth factor-A-induced angiogenesis by blocking receptor-2 (KDR/Flk-1) phosphorylation.
    Kwak HJ; Park MJ; Park CM; Moon SI; Yoo DH; Lee HC; Lee SH; Kim MS; Lee HW; Shin WS; Park IC; Rhee CH; Hong SI
    Int J Cancer; 2006 Jun; 118(11):2711-20. PubMed ID: 16388516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endostar attenuates melanoma tumor growth via its interruption of b-FGF mediated angiogenesis.
    Xiao L; Yang S; Hao J; Yuan X; Luo W; Jiang L; Hu Y; Fu Z; Zhang Y; Zou C
    Cancer Lett; 2015 Apr; 359(1):148-54. PubMed ID: 25597785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endostar Synergizes with Radiotherapy to Inhibit Angiogenesis of Cervical Cancer in a Subcutaneous Xenograft Mouse Model.
    Xu Z; Zhao X; Shu H; Luo W; Dong Y; Xu L; Zhu H; Zhao Q; Lv Y
    Front Biosci (Landmark Ed); 2022 Aug; 27(8):238. PubMed ID: 36042171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decursin and decursinol angelate inhibit VEGF-induced angiogenesis via suppression of the VEGFR-2-signaling pathway.
    Jung MH; Lee SH; Ahn EM; Lee YM
    Carcinogenesis; 2009 Apr; 30(4):655-61. PubMed ID: 19228635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wogonin suppresses tumor growth in vivo and VEGF-induced angiogenesis through inhibiting tyrosine phosphorylation of VEGFR2.
    Lu N; Gao Y; Ling Y; Chen Y; Yang Y; Gu HY; Qi Q; Liu W; Wang XT; You QD; Guo QL
    Life Sci; 2008 Apr; 82(17-18):956-63. PubMed ID: 18378261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel synthetic small molecule YF-452 inhibits tumor growth through antiangiogenesis by suppressing VEGF receptor 2 signaling.
    Liu Y; He Y; Yang F; Cong X; Wang J; Peng S; Gao D; Wang W; Lan L; Ying X; Liu M; Chen Y; Yi Z
    Sci China Life Sci; 2017 Feb; 60(2):202-214. PubMed ID: 28194552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pristimerin, a triterpenoid, inhibits tumor angiogenesis by targeting VEGFR2 activation.
    Mu X; Shi W; Sun L; Li H; Jiang Z; Zhang L
    Molecules; 2012 Jun; 17(6):6854-68. PubMed ID: 22669041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice.
    Kuba K; Matsumoto K; Date K; Shimura H; Tanaka M; Nakamura T
    Cancer Res; 2000 Dec; 60(23):6737-43. PubMed ID: 11118060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulfated fucoidan FP08S2 inhibits lung cancer cell growth in vivo by disrupting angiogenesis via targeting VEGFR2/VEGF and blocking VEGFR2/Erk/VEGF signaling.
    Chen H; Cong Q; Du Z; Liao W; Zhang L; Yao Y; Ding K
    Cancer Lett; 2016 Nov; 382(1):44-52. PubMed ID: 27569654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bee venom inhibits tumor angiogenesis and metastasis by inhibiting tyrosine phosphorylation of VEGFR-2 in LLC-tumor-bearing mice.
    Huh JE; Baek YH; Lee MH; Choi DY; Park DS; Lee JD
    Cancer Lett; 2010 Jun; 292(1):98-110. PubMed ID: 20188461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.